De Zhu Chen

Mr. De Zhu Chen

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

19 April 2024 in Medicine
Verified
Journal Article
Open access
LSLijun Su
Lijun Su
XWXiaoqi Wang
Xiaoqi Wang
FKFengguang Kang
Fengguang Kang
CGCaidi Gong
Caidi Gong
DCDe Zhu Chen
De Zhu Chen
Background: Tachycardia–bradycardia syndrome (TBS) is a subtype of sick sinus syndrome characterized by prolonged sinus pause (≥3 s) following termination of tachyarrhythmias, primarily atrial fibrillation (AF). There is controversy regarding whether the long-term prognosis of AF ablation is superior to pacemaker implantation. This study aimed to compare the effects of AF ablation and pacemaker therapy in patients with TBS. Methods: We conducted a comprehensive search of electronic databases, including PubMed, Cochrane, EmBase, Web of Science, and Chinese BioMedical, up until December 1, 2023. We included studies that reported the effects of AF ablation vs pacemaker therapy in patients with TBS. From this search, we identified 5 studies comprising 843 participants with TBS who underwent catheter AF ablation or pacemaker therapy. Results: Our meta-analysis revealed that AF ablation and pacemaker therapy had similar effects on cardiovascular death (odds ratio [OR] = 0.62 and 95% confidence interval [CI]: 0.14–2.65), procedural complications (OR = 1.53 and 95% CI: 0.67–3.48), and cardiovascular rehospitalization (OR = 0.57 and 95% CI: 0.26–1.22). However, AF ablation provided greater benefits than pacemaker therapy in terms of all-cause mortality (OR = 0.37 and 95% CI: 0.17–0.82), thromboembolism (OR = 0.25 and 95% CI: 0.12–0.49), stroke (OR = 0.28 and 95% CI: 0.13–0.57), heart failure (OR = 0.27 and 95% CI: 0.13–0.56), freedom from AF (OR = 23.32 and 95% CI: 7.46–72.92), and prevention of progression to persistent AF (OR = 0.12 and 95% CI: 0.06–0.24). Furthermore, AF ablation resulted in a reduced need for antiarrhythmic agents (OR = 0.21 and 95% CI: 0.08–0.59). Conclusion: AF ablation can effectively reduce the risk of all-cause mortality, thromboembolism, stroke, heart failure, and progression to persistent AF in patients with TBS. Additionally, it may eliminate the need for further pacemaker therapy in most cases after ablation. Therefore, AF ablation is considered superior to pacemaker therapy in the management of patients with TBS.

13 September 2025 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
ZXZhiyong Xie
Zhiyong Xie
RWRong Wei
Rong Wei
WZWenying Zhang
Wenying Zhang
XTXiaodong Tang
Xiaodong Tang
HCHang Chen
Hang Chen
YZYing Zhang
Ying Zhang

1 April 2025 in Archives of Medical Science
Verified
Journal Article
Closed access
ZZZhaoyan Zhao
Zhaoyan Zhao
YHYun Huang
Yun Huang
DCDe Zhu Chen
De Zhu Chen
YWYoufa Wang
Youfa Wang
Introduction: Urticaria is a widespread dermatological disorder that substantially affects patients’ quality of life. Current data on its worldwide impact are crucial for healthcare planning and resource distribution. By analyzing the Global Burden of Disease (GBD) Study 2021, we evaluated the burden of urticaria across global, regional, and national levels.Material and methods: A comprehensive analysis was performed using data from the GBD 2021 study. Key metrics included prevalence, incidence, and age-standardized rates, all calculated per 100,000 people. The results were analyzed across demographic factors including age groups, gender, and geographical locations.Results: From 1990 to 2021, global urticaria metrics demonstrated relative stability, with female patients consistently reporting higher rates. During this period, the number of prevalent cases increased from approximately 48 million to 66.5 million, with the age-standardized prevalence rate (ASPR) showing a slight rise from 866 to 868 per 100,000 population. The number of incident cases increased from about 85 million to 117 million, while the age-standardized incidence rate (ASIR) showed a marginal increase from 1,529 to 1,534 per 100,000. The global age-standardized DALY rate reached 52.1 per 100,000 in 2021, ranging from 27.7 in Portugal to 88.4 in Nepal. The disease burden was most pronounced in low-middle SDI regions and lowest in high SDI areas. At the country level, Nepal recorded the highest burden across all metrics, while Portugal showed the lowest.Conclusions: Our analysis spanning three decades revealed that while the overall global burden of urticaria has remained relatively stable, there has been a modest upward trend in both prevalence and incidence. Notable disparities have emerged, with disproportionate impacts observed across different populations: females experience higher rates of the condition, and low-middle SDI regions shoulder a greater disease burden. These patterns highlight the importance of developing focused healthcare strategies and optimizing resource distribution, particularly in heavily affected regions. Given the inherent limitations of GBD data, these findings should be interpreted with appropriate caution.

7 November 2025 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
MYMengqing Yang
Mengqing Yang
ZHZhengxin Hu
Zhengxin Hu
YHYun Huang
Yun Huang
GZGuohao Zhang
Guohao Zhang
FKFengguang Kang
Fengguang Kang
DCDe Zhu Chen
De Zhu Chen
Although nicotine use is a significant and potentially modifiable risk factor for delirium in ICU patients, evidence on the association between nicotine dependence (ND) and ICU delirium remains limited. This retrospective cohort study used the MIMIC-IV v3.1 database and included adult patients admitted to the ICU for ≥ 24 h with documented delirium assessments. Patients with schizophrenia, dementia, depression, alcohol abuse, or cerebrovascular disease were excluded. Patients were classified into ND and non-ND groups. The primary outcome was ICU delirium incidence; secondary outcomes included in-hospital mortality, ICU mortality, hospital length of stay, and ICU length of stay. Confounders were balanced using 1:1 propensity score matching (PSM). Cox regression and competing risk models were used to assess the association between ND and delirium. Subgroup and sensitivity analyses were performed, and the effects of ICD coding versions and NRT treatment were also evaluated. A total of 24,043 patients were included, with 2,662 (11.07%) in the ND group. After PSM, baseline characteristics were balanced. The ND group had a significantly higher incidence of delirium than the non-ND group (30.8% vs. 27.2%, P = 0.004), with no significant differences in mortality or length of stay. Multivariate Cox and competing risk models confirmed that ND was independently associated with increased ICU delirium risk. Findings remained consistent in PSM and sensitivity analyses. Nicotine dependence significantly increases the risk of ICU delirium. These results highlight the need for targeted risk assessment and intervention strategies in ND patients admitted to the ICU.